Treatment of cutaneous lesions in patients with lupus erythematosus.
After proper classification of cutaneous lesions in LE patients and extensive evaluation, we can begin to approach effective therapy. Patients with cutaneous lupus erythematosus (discoid LE or subacute cutaneous LE) generally have a favorable prognosis and can be managed with safe yet effective therapy. Sunscreens are the most important topical therapy. Intralesional corticosteroids are an effective local adjunctive therapy, useful in bringing lesions under control. Systemic therapy with antimalarials, either used singly or in combination, are usually effective. When "standard" therapy fails, azathioprine, retinoids, or occasionally dapsone may be effective.
Callen
J P
JP
Department of Medicine, University of Louisville School of Medicine, Kentucky.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D002908:Chronic Disease; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000188:drug therapy / Q000628:therapy*; D013473:Sunscreening Agents / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000962:Antimalarials; D013473:Sunscreening Agents